Drug Repositioning for Alzheimer’s Disease: Finding Hidden Clues in Old Drugs
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Drug Repositioning for Alzheimer’s Disease: Finding Hidden Clues in Old Drugs
Authors
Keywords
-
Journal
JOURNAL OF ALZHEIMERS DISEASE
Volume -, Issue -, Pages 1-16
Publisher
IOS Press
Online
2020-03-03
DOI
10.3233/jad-200049
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Rapamycin and Alzheimer’s disease: Time for a clinical trial?
- (2019) Matt Kaeberlein et al. Science Translational Medicine
- Treatment with the glutamate modulator riluzole prevents early life stress-induced cognitive deficits and impairments in synaptic plasticity in APPswe/PS1dE9 mice
- (2019) Sylvie L. Lesuis et al. NEUROPHARMACOLOGY
- Aberrant Excitatory–Inhibitory Synaptic Mechanisms in Entorhinal Cortex Microcircuits During the Pathogenesis of Alzheimer’s Disease
- (2019) Alexandra L Petrache et al. CEREBRAL CORTEX
- The key genes, phosphoproteins, processes, and pathways affected by efavirenz-activated CYP46A1 in the amyloid-decreasing paradigm of efavirenz treatment
- (2019) Alexey M. Petrov et al. FASEB JOURNAL
- Senolytic therapy alleviates Aβ-associated oligodendrocyte progenitor cell senescence and cognitive deficits in an Alzheimer’s disease model
- (2019) Peisu Zhang et al. NATURE NEUROSCIENCE
- Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer’s disease: study protocol for a randomised controlled trial (ELAD study)
- (2019) Grazia Daniela Femminella et al. Trials
- Development of a Multicomponent Intervention to Prevent Alzheimer's Disease
- (2019) Satoshi Saito et al. Frontiers in Neurology
- Lithium as a Treatment for Alzheimer’s Disease: The Systems Pharmacology Perspective
- (2019) Harald Hampel et al. JOURNAL OF ALZHEIMERS DISEASE
- Computer-aided drug repurposing for cancer therapy: Approaches and opportunities to challenge anticancer targets
- (2019) Carla Mottini et al. SEMINARS IN CANCER BIOLOGY
- Escitalopram for agitation in Alzheimer's disease (S-CitAD): Methods and design of an investigator-initiated, randomized, controlled, multicenter clinical trial
- (2019) Stephan Ehrhardt et al. Alzheimers & Dementia
- Efficacy and Safety of Brexpiprazole for the Treatment of Agitation in Alzheimer's Dementia: Two 12-Week, Randomized, Double-Blind, Placebo-Controlled Trials
- (2019) George T. Grossberg et al. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY
- Long-Term Dabigatran Treatment Delays Alzheimer’s Disease Pathogenesis in the TgCRND8 Mouse Model
- (2019) Marta Cortes-Canteli et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- A multiomics approach to heterogeneity in Alzheimer’s disease: focused review and roadmap
- (2019) AmanPreet Badhwar et al. BRAIN
- Old wine in new bottles: Drug repurposing in oncology
- (2019) Michał Antoszczak et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Challenges and opportunities with drug repurposing: finding strategies to find alternative uses of therapeutics
- (2019) Alan Talevi et al. Expert Opinion on Drug Discovery
- Role of Nicotinamide Adenine Dinucleotide and Related Precursors as Therapeutic Targets for Age-Related Degenerative Diseases: Rationale, Biochemistry, Pharmacokinetics, and Outcomes
- (2018) Nady Braidy et al. ANTIOXIDANTS & REDOX SIGNALING
- An Overview on the Clinical Development of Tau-Based Therapeutics
- (2018) Miguel Medina INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Metals and Alzheimer’s Disease: How Far Have We Come in the Clinic?
- (2018) Paul A. Adlard et al. JOURNAL OF ALZHEIMERS DISEASE
- Nose-to-brain drug delivery: An update on clinical challenges and progress towards approval of anti-Alzheimer drugs
- (2018) Mukta Agrawal et al. JOURNAL OF CONTROLLED RELEASE
- Granulocyte-macrophage colony-stimulating factor neuroprotective activities in Alzheimer’s disease mice
- (2018) Tomomi Kiyota et al. JOURNAL OF NEUROIMMUNOLOGY
- Intranasal insulin in Alzheimer’s dementia or mild cognitive impairment: a systematic review
- (2018) Konstantinos Ioannis Avgerinos et al. JOURNAL OF NEUROLOGY
- Sequential drug treatment algorithm for agitation and aggression in Alzheimer’s and mixed dementia
- (2018) Simon JC Davies et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Microbes and Alzheimer’s Disease: New Findings Call for a Paradigm Change
- (2018) Jürgen G. Haas et al. TRENDS IN NEUROSCIENCES
- The Apathy in Dementia Methylphenidate Trial 2 (ADMET 2): study protocol for a randomized controlled trial
- (2018) Roberta W. Scherer et al. Trials
- Cromolyn Reduces Levels of the Alzheimer’s Disease-Associated Amyloid β-Protein by Promoting Microglial Phagocytosis
- (2018) Can Zhang et al. Scientific Reports
- NSAID Exposure and Risk of Alzheimer's Disease: An Updated Meta-Analysis From Cohort Studies
- (2018) Caixia Zhang et al. Frontiers in Aging Neuroscience
- The Therapeutic Potential of Metformin in Neurodegenerative Diseases
- (2018) Carola Rotermund et al. Frontiers in Endocrinology
- Insights into the Drug Repositioning Applied to the Alzheimer's Disease Treatment and Future Perspectives
- (2018) Alexandre A. de Castro et al. Current Alzheimer Research
- A novel therapeutic potential of cysteinyl leukotrienes and their receptors modulation in the neurological complications associated with Alzheimer's disease
- (2018) Syed Obaidur Rahman et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Pleiotropic Benefits of the Angiotensin Receptor Blocker Candesartan in a Mouse Model of Alzheimer Disease
- (2018) Lianne J. Trigiani et al. HYPERTENSION
- The Gut Microbiota and Alzheimer’s Disease
- (2017) Chunmei Jiang et al. JOURNAL OF ALZHEIMERS DISEASE
- The Association Between the Use of Zolpidem and the Risk of Alzheimer's Disease Among Older People
- (2017) Hui-Ting Cheng et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- Silent hippocampal seizures and spikes identified by foramen ovale electrodes in Alzheimer's disease
- (2017) Alice D Lam et al. NATURE MEDICINE
- Transparency Policies of the European Medicines Agency: Has the Paradigm Shifted?
- (2017) Daria Kim Medical Law Review
- Forxiga (dapagliflozin): Plausible role in the treatment of diabetes-associated neurological disorders
- (2016) Sibhghatulla Shaikh et al. BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY
- Inflammation, Antiinflammatory Agents, and Alzheimer’s Disease: The Last 22 Years
- (2016) Patrick L. McGeer et al. JOURNAL OF ALZHEIMERS DISEASE
- Early role of vascular dysregulation on late-onset Alzheimer’s disease based on multifactorial data-driven analysis
- (2016) Y. Iturria-Medina et al. Nature Communications
- Drug Repurposing
- (2016) CHEMICAL & ENGINEERING NEWS
- Alzheimer's disease pathology is attenuated in a CD38-deficient mouse model
- (2015) Eran Blacher et al. ANNALS OF NEUROLOGY
- Non-Steroidal Anti-Inflammatory Drugs as a Treatment for Alzheimer’s Disease: A Systematic Review and Meta-Analysis of Treatment Effect
- (2015) Marina Miguel-Álvarez et al. DRUGS & AGING
- Critical role of acetylation in tau-mediated neurodegeneration and cognitive deficits
- (2015) Sang-Won Min et al. NATURE MEDICINE
- Allopregnanolone Preclinical Acute Pharmacokinetic and Pharmacodynamic Studies to Predict Tolerability and Efficacy for Alzheimer’s Disease
- (2015) Ronald W. Irwin et al. PLoS One
- Comorbidity and dementia: a scoping review of the literature
- (2014) Frances Bunn et al. BMC Medicine
- Angiotensin II type 1 receptor blocker losartan prevents and rescues cerebrovascular, neuropathological and cognitive deficits in an Alzheimer’s disease model
- (2014) Brice Ongali et al. NEUROBIOLOGY OF DISEASE
- Cilostazol Add-On Therapy in Patients with Mild Dementia Receiving Donepezil: A Retrospective Study
- (2014) Masafumi Ihara et al. PLoS One
- New Therapeutic Approaches for Alzheimer’s Disease and Cerebral Amyloid Angiopathy
- (2014) Satoshi Saito et al. Frontiers in Aging Neuroscience
- Overcoming obstacles to repurposing for neurodegenerative disease
- (2014) Diana W. Shineman et al. Annals of Clinical and Translational Neurology
- Phosphodiesterase III inhibitor promotes drainage of cerebrovascular β-amyloid
- (2014) Takakuni Maki et al. Annals of Clinical and Translational Neurology
- Vascular and neurodegenerative pathways—will they meet?
- (2013) Raj N. Kalaria et al. Nature Reviews Neurology
- Long-Term Treatment of Thalidomide Ameliorates Amyloid-Like Pathology through Inhibition of β-Secretase in a Mouse Model of Alzheimer’s Disease
- (2013) Ping He et al. PLoS One
- Cilostazol improves cognitive function in patients with mild cognitive impairment: a retrospective analysis
- (2013) Akihiko Taguchi et al. Psychogeriatrics
- Diabetes mellitus and risk of dementia: A meta-analysis of prospective observational studies
- (2013) Kapil Gudala et al. Journal of Diabetes Investigation
- The link between altered cholesterol metabolism and Alzheimer's disease
- (2012) Paola Gamba et al. Annals of the New York Academy of Sciences
- Does vascular pathology contribute to Alzheimer changes?
- (2012) Raj N. Kalaria et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Diagnosing the decline in pharmaceutical R&D efficiency
- (2012) Jack W. Scannell et al. NATURE REVIEWS DRUG DISCOVERY
- Perindopril, a centrally active angiotensin-converting enzyme inhibitor, prevents cognitive impairment in mouse models of Alzheimer's disease
- (2011) Yi-Fei Dong et al. FASEB JOURNAL
- Evergreening: a common practice to protect new drugs
- (2011) Kate S Gaudry NATURE BIOTECHNOLOGY
- Inducing Autophagy by Rapamycin Before, but Not After, the Formation of Plaques and Tangles Ameliorates Cognitive Deficits
- (2011) Smita Majumder et al. PLoS One
- Powerful beneficial effects of benfotiamine on cognitive impairment and -amyloid deposition in amyloid precursor protein/presenilin-1 transgenic mice
- (2010) X. Pan et al. BRAIN
- How to improve R&D productivity: the pharmaceutical industry's grand challenge
- (2010) Steven M. Paul et al. NATURE REVIEWS DRUG DISCOVERY
- Cortico-hippocampal hyperexcitability in synapsin I/II/III knockout mice: age-dependency and response to the antiepileptic drug levetiracetam
- (2010) D. Boido et al. NEUROSCIENCE
- Targeting the correct HDAC(s) to treat cognitive disorders
- (2010) André Fischer et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Amyloid precursor protein transgenic mouse models and Alzheimer's disease: Understanding the paradigms, limitations, and contributions
- (2009) Tyler A. Kokjohn et al. Alzheimers & Dementia
- Cognitive Deficit in Amyloid-β–Injected Mice Was Improved by Pretreatment With a Low Dose of Telmisartan Partly Because of Peroxisome Proliferator-Activated Receptor-γ Activation
- (2009) Kana Tsukuda et al. HYPERTENSION
- Nicotinamide Restores Cognition in Alzheimer's Disease Transgenic Mice via a Mechanism Involving Sirtuin Inhibition and Selective Reduction of Thr231-Phosphotau
- (2008) K. N. Green et al. JOURNAL OF NEUROSCIENCE
- Protective effects of NSAIDs on the development of Alzheimer disease
- (2008) Steven C. Vlad et al. NEUROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More